Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Multicentric Phase III Study Evaluating the Efficacy of Cicaderma vs Standard Management of Each Site in Preventing Radiodermatitis After Adjuvant Post-operative Breast Irradiation in Patients With Non-metastatic Breast Cancer

NCT04300829 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04300829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04300829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Multicentric Phase III Study Evaluating the Efficacy of Cicaderma vs Standard Management of Each Site in Preventing Radiodermatitis After Adjuvant Post-operative Breast Irradiation in Patients With Non-metastatic Breast Cancer
Lead sponsor
Centre Leon Berard
Phase
Phase 3
Overall status
Unknown status
Start date
June 6, 2020
Completion date
October 9, 2022
Enrollment
248 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast adenocarcinoma, radiation dermatitis, radiation toxicity